Form 4 for BSX Boston Scientific
Accepted 2022-05-06 00:00:00 ET · period of report 2022-05-05 · accession 0001225208-22-006635 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-06 | 2022-05-05 | BSX | Zane Ellen M | Dir | A - Grant | $0.00 | +4,877 | 41.7K | +13% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-05 | A | A | 4,877 | $0.00 | 41,683 | D | — | — | (F1) Annual equity award in the form of restricted stock vesting in full upon the next annual meeting of stockholders. Reflects a value of $205,000 divided by the closing price of common stock on the date of grant. |